Ex-servicemen and their dependants enrolled under the Ex-Servicemen Contributory Health Scheme (ECHS) may face difficulties when prescribed medicines are unavailable at their ECHS Polyclinic. In such cases, beneficiaries should know the prescribed procedure for obtaining medicines through an Authorised Local Chemist (ALC) and the circumstances in which reimbursement may be claimed.
An important clarification is available in an official ECHS advisory dated 3 April 2025. It states that if an Authorised Local Chemist fails to supply indented medicines, the ECHS beneficiary may procure them from another chemist and submit a reimbursement claim. The advisory also directs that the difference in cost, subject to the applicable terms, be recovered from the defaulting vendor.
This article explains the rules, the role of the authorised chemist, the precautions beneficiaries should take before purchasing medicines, and the steps to follow if the medicine is unavailable.
1. What is an ECHS Authorised Local Chemist (ALC)?
An Authorised Local Chemist is a pharmacy engaged by ECHS under an authorised arrangement to supply medicines that are unavailable at an ECHS Polyclinic. The system is intended to reduce inconvenience and prevent beneficiaries from having to purchase prescribed medicines from their own pockets unnecessarily.
The normal process is:
- The ECHS doctor prescribes the required medicines.
- Medicines unavailable at the Polyclinic are identified as Not Available (NA).
- The Polyclinic arranges procurement through its authorised local chemist.
- The beneficiary receives the medicines through the prescribed ECHS procedure.
The official ECHS brochure explains that when medicines are unavailable both at the Polyclinic and with the ALC, the beneficiary may be given an NA endorsement on the prescription to purchase the medicines and claim reimbursement, subject to the applicable rules.
2. Can an ECHS beneficiary purchase unavailable medicines and claim reimbursement?
Yes, reimbursement may be possible, but beneficiaries must follow the applicable procedure. The distinction between routine non-availability and failure by an authorised vendor is important.
| Situation | What the beneficiary should do |
| Medicine unavailable at the ECHS Polyclinic | Ask the Polyclinic to arrange supply through its ALC. |
| Medicine unavailable with the ALC as well | Obtain the prescribed NA endorsement or certificate and follow the Polyclinic’s reimbursement procedure. |
| ALC fails to supply medicines already indented | Refer to the official advisory dated 3 April 2025, which permits procurement from another chemist and submission of a reimbursement claim. |
| Beneficiary wants to buy medicines without first approaching ECHS | Do not assume reimbursement will be admissible; obtain prior clarification or the required endorsement wherever possible. |
The ECHS FAQs, dated 10 April 2023, specifically address the question of buying medicines from the market. They state that medicines unavailable at both the Polyclinic and ALC may be purchased from the open market and reimbursement claimed, provided the prescription records the medicine as NA. The later 2025 advisory also addresses failure by the ALC to supply indented medicines.
Important: The 2023 FAQs are general guidance, not a substitute for the latest applicable policy letter. Beneficiaries should follow the current written instructions issued by ECHS for their particular case.
3. Must medicines be purchased only from an authorised pharmacy?
This issue needs to be understood carefully.
The ALC is the preferred channel for medicines unavailable at the Polyclinic. However, the official ECHS advisory of 3 April 2025 expressly provides that where an ALC fails to supply medicines already indented, the beneficiary may procure them from any other chemist and submit a reimbursement claim.
Therefore, it would be inaccurate to state that reimbursement is always restricted to purchases from an ALC. The circumstances and documentary requirements matter.
Beneficiaries should follow these precautions:
- Ask the Polyclinic to record the medicine as Not Available (NA) and arrange supply through the ALC.
- If the ALC also cannot supply the medicine, obtain the required NA endorsement or certificate.
- If the ALC fails to supply an already-indented medicine, preserve evidence of the indented order and non-supply, and refer to the 2025 advisory.
- Purchase the prescribed medicine from a legitimate, licensed pharmacy and retain the original bill.
- Confirm the claim submission procedure and any applicable reimbursement limits with the parent ECHS Polyclinic.
The distinction is between a pharmacy being licensed to sell medicines and being authorised under the ECHS procurement arrangement. An ordinary pharmacy is not automatically an ECHS ALC, but the 2025 advisory recognises procurement from another chemist in the specified non-supply situation.
4. What are the responsibilities of the Authorised Local Chemist?
The ECHS advisory dated 3 April 2025 addresses complaints that some ALCs were not supplying all indented medicines and were allegedly offering medicines directly to beneficiaries for cash against NA certificates.
The advisory reiterates the following safeguards:
- An ALC should supply indented medicines and should not refuse supply without an authentic reason.
- In an emergency, indented medicines may need to be delivered to the beneficiary’s residence as directed by the Officer-in-Charge (OIC) of the Polyclinic.
- A penalty of ₹100 per medicine item, per beneficiary, for each instance of non-supply or delay is specified in the advisory.
- Where the ALC fails to supply indented medicines, the beneficiary may procure them from another chemist and submit a reimbursement claim.
- The advisory provides for recovery of the relevant price difference from the defaulting vendor’s future bills or performance security, in addition to the specified penalty.
- An ALC must not reimburse cash directly to a beneficiary against bills submitted for indented but unsupplied medicines.
These measures are intended to improve accountability and prevent beneficiaries from being unnecessarily inconvenienced. Their implementation in an individual case remains subject to the applicable ECHS instructions.
5. Step-by-step procedure to claim reimbursement
Step 1: Obtain a valid prescription
Ensure that the medicine is prescribed by the appropriate ECHS medical authority or otherwise covered by the applicable ECHS prescription rules.
Step 2: Ask the Polyclinic to arrange the medicine
Request supply through the ALC. If the medicine is unavailable, ask for the appropriate NA endorsement or documentation.
Step 3: Establish the non-availability or non-supply
If both the Polyclinic and ALC cannot supply the medicine, follow the market-purchase procedure. If an ALC fails to supply an indented medicine, retain evidence of that failure.
Step 4: Purchase the prescribed medicine and retain documents
Keep the original pharmacy bill, prescription, NA endorsement, and any written communication or indented-medicine record relevant to the case.
Step 5: Submit the claim through ECHS
Submit the prescribed claim documents to the parent Polyclinic or through the claim channel it specifies. Obtain an acknowledgement and retain a copy for follow-up.
This is a practical checklist, not a replacement for the prescribed claim form or any additional documentation required by the relevant ECHS authority.
6. Will the full amount paid by the beneficiary be reimbursed?
Not necessarily. Beneficiaries should distinguish between the amount paid at the pharmacy and the amount admissible under ECHS rules.
ECHS guidance states that reimbursement is generally governed by the applicable ECHS/CGHS rates. The admissible amount may therefore differ from the retail amount paid, depending on the applicable policy and circumstances of the claim.
Before making a purchase, beneficiaries should confirm:
- Whether the medicine is covered under the applicable ECHS policy.
- Whether the prescribed NA endorsement or other approval is required.
- Whether reimbursement will be calculated at the actual purchase price or the applicable admissible rate.
- Whether any additional sanction is necessary for the particular medicine.
Do not assume that buying a more expensive brand or a medicine outside the applicable list will automatically qualify for full reimbursement.
7. What documents should beneficiaries preserve?
The precise document checklist may vary according to the nature of the claim. As a practical precaution, retain the following:
- Valid ECHS Smart Card details of the beneficiary.
- Original prescription containing the prescribed medicine and dosage.
- NA endorsement or certificate issued by the Polyclinic, wherever required.
- Original, itemised pharmacy bill showing the medicine name, quantity, date and amount.
- Record of the ALC indent or written confirmation of non-supply, where applicable.
- Any approval, claim form or supporting document required by the parent Polyclinic.
- Acknowledgement or claim reference number after submission.
Keep photocopies or digital scans of all submitted documents. Ask the Polyclinic to confirm the current submission deadline and whether originals must be submitted.
8. What if the Polyclinic or ALC does not cooperate?
If an ALC repeatedly fails to supply indented medicines, the beneficiary should raise the matter with the OIC of the ECHS Polyclinic. If the issue remains unresolved, it may be escalated to the concerned ECHS Regional Centre or the appropriate higher authority.
The complaint should clearly mention:
- Name of the medicine and date of prescription.
- Date on which the medicine was indented or declared unavailable.
- Details of the non-supply or delay.
- Copies of relevant prescriptions, bills and communications.
- Relief requested, such as supply of the medicine or processing of an admissible reimbursement claim.
The official advisory specifically recognises vendor non-supply as an issue attracting penalties and other contractual consequences.
For official information, visit the ECHS official policy page or contact the parent Polyclinic. The official ECHS website also lists the central helpline as 1800-114-115.
9. Frequently Asked Questions (FAQs)
Q1. Can an ECHS beneficiary buy medicines from the market if they are unavailable at the Polyclinic?
Yes. ECHS FAQs state that medicines unavailable at both the Polyclinic and ALC may be purchased from the open market and reimbursement claimed, provided the prescription shows the medicine as NA. The applicable procedure must be followed.
Q2. Is an NA certificate necessary for reimbursement?
The official FAQs specify an NA endorsement on the prescription for the situation where the medicine is unavailable at both the Polyclinic and ALC. Follow the current instructions of the parent Polyclinic for the required form of endorsement or certificate.
Q3. Can I buy the medicine from a pharmacy other than the authorised local chemist?
The ECHS advisory dated 3 April 2025 permits procurement from another chemist when the ALC fails to supply indented medicines. This should not be interpreted as unrestricted permission to purchase medicines independently in every situation.
Q4. Can the authorised chemist pay cash directly to the beneficiary against the medicine bill?
The April 2025 advisory states that the ALC must not reimburse cash directly to beneficiaries against bills submitted for indented but unsupplied medicines. The beneficiary should follow the prescribed ECHS claim procedure.
Q5. Is full reimbursement guaranteed?
No. Reimbursement depends on the applicable policy, supporting documents and admissible rates. A beneficiary should not assume that the entire retail amount will automatically be sanctioned.
Q6. What should I do if the reimbursement claim is rejected?
Ask the Polyclinic for the written reason for rejection. If the beneficiary believes that the claim complies with the applicable policy, submit a representation with supporting documents to the OIC Polyclinic and, where necessary, the Regional Centre or other competent authority.
Conclusion
ECHS beneficiaries should not have to bear avoidable expenses because prescribed medicines are unavailable at their Polyclinic or because an authorised vendor fails to supply them.
The normal route is to obtain medicines through the ECHS Polyclinic and its Authorised Local Chemist. Where both cannot supply the prescribed medicine, the official ECHS FAQs provide for market purchase and a reimbursement claim with the required NA endorsement. In addition, the advisory dated 3 April 2025 specifically addresses reimbursement where the ALC fails to supply indented medicines.
The most important precaution is to document non-availability or non-supply before purchasing medicines and to follow the current ECHS claim procedure. This can help beneficiaries avoid unnecessary disputes and improve the prospects of a properly admissible reimbursement claim.